News About: Pharm. Industry
Leading drug firm’s vice president is still in office
The sudden resignation of a top executive from one of the nation's leading drug companies has surprised the industry, but this was happening.
The industry is abuzz with speculation that Dongwha Pharm’s vice preside...
Ousting Wales Korea
Calls are growing among the Korea Pharmaceutical Manufacturers Association (KPMA) to have Wales Korea expelled from the association, as the police zero in on the alleged fabrication of expiration dates on all of Wales...
Daewoong’s Ursa mired in efficacy dispute
Daewoong Pharmaceutical, one of the country's biggest drug makers, has built its reputation on its immensely popular liver medicine, Ursa (ursodeoxycholic acid; UDCA), but its efficacy is mired in controversy due to a...
Government urged not to squeeze drug firms
Domestic drug companies and wholesalers have expressed concern about the country’s pharmaceutical industry.
“We will stop making investments in research and development (R&D) and stop bringing quality products if p...
Korea to spend W1.6 trillion to support drug firms by 2020The government unveiled a set of plans last year to nurture 12 globally competitive pharmaceutical companies by 2020.
The plans are intended to develop Korea into the seventh...
|
Contest for Korean name of generic drug gains positive responses
The contest aiming to seek an alternative Korean name of generic drug, which has given a negative impact to the public as “a copied drug”, appealed much to the public, according to the Korea Pharmaceutical Manufacture...
Concerns growing over cash reward system
Concerns are growing in local pharmaceutical industry over the government’s cash reward system whose implementation has been delayed until end-December this year.
Under the system, when a hospital buys a drug for l...
Korean drugmakers seeking to strengthen strategic alliances with foreign-invested firms
A growing number of domestic firms have already established strategic alliance with the Korean units of multinational firms for co-marketing and/or co-promotion of new drugs to effectively minimize outlays for sales a...
Jeil, Takeda Korea to cooperate over new treatment of type 2 diabetes
Jeil Pharm and Takeda Korea announced Wednesday that they have concluded an agreement to co-promote Nesina (alogliptin), Takeda’s new treatment for type 2 diabetes in adults as adjuncts to diet and exercise.
Nesina...
CJ holds preliminary ceremony to launch Exone
The pharmaceutical unit of CJ CheilJedang, the country’s largest food manufacturer, on Tuesday held an in-house ceremony in Seoul ahead of its launching of Exone, an incrementally modified drug (IMD) of Swiss based No...
